Key features and findings about liraglutide include: Glycemic Efficacy: Liraglutide showed greater A1c reduction than exenatide in trials
At the 12mg dose, that figure jumped to 20.9%
If you haven't seen the desired results despite your best efforts during this time, it strengthens the case for medical necessity when you ask for medication approval
In AWARD-10 [31], a 24-week, randomized, double-blind, placebo-controlled trial evaluating once-weekly dulaglutide (administered at either 1.5 or 0.75 mg) as add-on therapy to SGLT2is in a total of 424 patients with inadequately controlled T2DM, only one episode of severe hypoglycemia was reported throughout the study, in a patient treated with dulaglutide 0.75 mg, confirming the very low incidence of serious hypoglycemia with GLP-1RAs in combination with SGLT2is [31]
And the SYNERGY program targets metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease
GPx activity was linked to a decrease in the absorbance of the coloured Cu(I)neocuproine complex
